Honkamp Krueger Financial Services »

Silverback Therapeutics shares owned by Honkamp Krueger Financial Services

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Honkamp Krueger Financial Services from 13F filings

Historical chart of Honkamp Krueger Financial Services investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Honkamp Krueger Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Honkamp Krueger Financial Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $329k 32k 10.22
2023-12-31 $176k 32k 5.48
2023-09-30 $122k 32k 3.78
2023-06-30 $216k 32k 6.70
2023-03-31 $210k 32k 6.51
2022-12-31 $274k 32k 8.53
2022-09-30 $170k 32k 5.28
2022-06-30 $136k 32k 4.23
2022-03-31 $113k 32k 3.51